CDEK
← All organizations

Roxane Laboratories

For profitContributed to NMEWebsite ↗

Also known as: ROXANE

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 2, 1999

First marketed drug

Nov 24, 1971

First NDA

Jul 9, 1993

Last known activity

Aug 1, 2014

Acquired by Boehringer Ingelheim on Jan 1, 1978

Timeline

1880s

  1. Jan 1, 1885

    Roxane Laboratories— Founded

1970s

  1. Aug 5, 1977

    imipramine— Marketing Organization

  2. Jan 1, 1978

    Boehringer Ingelheim— Acquired By

1980s

  1. Feb 19, 1982

    potassium iodide— NDA Secondary Org

1990s

  1. Jul 9, 1993

    levomethadyl acetate— NDA Organization

Drugs by trial phase (46 distinct, 101 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (73)

Recent trials (50)

Details

Founded
Columbus, OH, US Jan 1, 1885
First NDA
Jul 9, 1993
Last known activity
Aug 1, 2014

Designations held

  • Orphan drug
  • Priority review

Notes

The company was formerly known as Philips Roxane and changed its name to Roxane Laboratories, Inc. in 1978